U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07240012) titled 'Automated Insulin Delivery Versus Usual Insulin Treatment Modality for Pregnant Women With Type 1 Diabetes: A Multi-center Randomized Controlled Trial - the AID-DM Study' on Nov. 16.

Brief Summary: Investigate whether the use of the CamAPS FX AID (Automated insulin delivery) system initiated during pregnancy planning or in early pregnancy improves time in glycemic targets and fetal growth in women with type 1 diabetes compared to usual insulin treatment modality combined with CGM (Continuous Glucose Monitoring).

Study Start Date: Dec. 01

Study Type: INTERVENTIONAL

Condition: Diabete Type 1 Pregnancy Complications

Intervention: ...